Quarterly report [Sections 13 or 15(d)]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Narrative)

v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Narrative) - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES        
R&D tax credits received $ 704,000 $ 1,349,000    
Federally insured limit amount 250,000      
Cash and cash equivalents 1,720,000 $ 4,357,000 $ 2,338,000 $ 2,815,000
Marketable securities outstanding balance 0   $ 0  
Amount in excess of FDIC insurance amount $ 1,220,000